INJECTABLE
  • Animeal

INJECTABLE

MUCOMIX INJ

MUCOMIX INJ

By SAMARTH

₹ 50
₹ 50
Tax included. Shipping calculated at checkout.

In Stock

Pack - 2mL
Expires on or after: Feb, 2027
Title

Check Availability

Rapid 3-4 Day Delivery,Tiny Extra Fee!

  • AnimealPet Safe
  • AnimealBest Quality
  • AnimealFast Delivery
  • AnimealSecure Payment
View full details

Mucomix Injection by Samarth Life Sciences is a prescription-only, clinically critical injectable formulation of N-Acetylcysteine (NAC), designed to address two of the most urgent medical emergencies encountered in both human and veterinary clinical settings paracetamol (acetaminophen) toxicity and the management of thick, obstructive mucus secretions in respiratory tract diseases. Paracetamol overdose is one of the leading causes of acute liver failure, and the therapeutic window for effective intervention is dangerously narrow making the rapid, accurate administration of this antidote a life-or-death decision. Simultaneously, in conditions such as bronchitis, emphysema, bronchiectasis, and cystic fibrosis, excessive and viscous mucus can severely compromise airway patency and respiratory function. Mucomix Injection targets both these pathologies through a single, well-established active molecule with decades of clinical validation. Animeal is proud to offer Mucomix Injection as part of our curated selection of critical care pharmaceutical solutions for veterinary use, available for prescription-guided purchase through our platform.

Ingredients:

N-Acetylcysteine (NAC) 400 mg per 2 ml ampoule: (N-acetyl-L-cysteine; CAS No. 616-91-1) N-Acetylcysteine is a synthetic derivative of the naturally occurring amino acid L-cysteine, and its therapeutic action operates across two distinct but interconnected physiological pathways.

As a Mucolytic Agent: NAC directly targets the disulfide bonds within the glycoprotein matrix of mucus. At the biochemical level, its free thiol (-SH) group cleaves the disulfide bridges that maintain the structural rigidity and high viscosity of mucus polymers. This depolymerisation of mucus macromolecules reduces mucosal viscosity and elasticity, facilitating mucociliary clearance and making expectoration significantly easier. This action alleviates airway obstruction and improves respiratory function in conditions characterised by mucus hypersecretion.

As a Hepatoprotective Antidote: In the context of paracetamol toxicity, NAC functions as both a direct precursor to glutathione (GSH) and as a direct antioxidant. When paracetamol is metabolised in excess, the cytochrome P450 enzyme system generates a highly reactive hepatotoxic metabolite, N-acetyl-p-benzoquinone imine (NAPQI). Under normal conditions, NAPQI is rapidly conjugated and neutralised by hepatic glutathione. In overdose scenarios, glutathione stores become rapidly depleted, allowing NAPQI to accumulate and covalently bind to hepatocellular proteins, triggering oxidative stress, mitochondrial dysfunction, and ultimately necrotic cell death. NAC replenishes intracellular cysteine stores the rate-limiting substrate for glutathione biosynthesis thereby restoring GSH levels, neutralising NAPQI, and protecting hepatocytes from irreversible damage. Additionally, NAC exerts direct antioxidant activity, scavenging reactive oxygen species (ROS) independently of the GSH pathway, and improves microcirculatory blood flow in the liver, further reinforcing hepatic recovery.

Critical-Window Liver Protection in Toxicity Emergencies:

Mucomix Injection delivers N-Acetylcysteine intravenously, restoring hepatic glutathione reserves within the critical 8-hour post-overdose window during which liver damage is most reversible. For cases presenting beyond this window, the formulation continues to provide meaningful hepatoprotection up to 24 hours post-ingestion, making it the preferred choice of emergency and veterinary clinicians managing acute paracetamol toxicity in companion animals and human patients alike.

Cutting-Edge Mucolytic Action for Respiratory Clearance:

By directly cleaving the molecular bonds that give pathological mucus its gel-like consistency, Mucomix Injection restores natural mucociliary clearance and alleviates the airway obstruction that defines chronic bronchopulmonary conditions. In pets suffering from upper respiratory infections or structural lung diseases, this mucus-thinning action can be the difference between distressed, laboured breathing and restored respiratory comfort.

Dual-Pathway Antioxidant Defence:

Beyond its role as a glutathione precursor, NAC directly scavenges free radicals and reactive oxygen species at the cellular level, providing a second independent layer of antioxidant protection. This dual mechanism makes Mucomix Injection particularly valuable in clinical scenarios where oxidative stress from toxin exposure or chronic pulmonary inflammation is driving progressive organ or tissue damage.

Rapid Intravenous Bioavailability:

As an injectable formulation administered intravenously, Mucomix bypasses the limitations of oral bioavailability entirely, delivering therapeutic concentrations of N-Acetylcysteine directly into systemic circulation with immediate onset. This pharmacokinetic advantage is decisive in time-critical emergencies, where every hour without adequate antidotal intervention increases the risk of irreversible liver damage.

Clinically Validated Safety Profile:

N-Acetylcysteine has an extensive, well-characterised safety record across decades of clinical use in both human and veterinary medicine. Its side effect profile is well understood and manageable by qualified clinicians, and its mechanism of action is non-toxic to healthy hepatocytes, making it a reliable tool in the hands of experienced veterinary and medical professionals.

How to Use:

Mucomix Injection must be administered exclusively by a qualified veterinarian or licensed medical professional in a clinical or hospital setting. It is not suitable for self-administration under any circumstances. The injection is delivered as an intravenous infusion (IV drip) and must be appropriately diluted in a compatible IV solution as directed by the attending clinician. The dose, infusion rate, and duration of treatment are determined by the veterinarian or physician based on the species, body weight, the nature and severity of the presenting condition, and the time elapsed since toxic exposure. In the context of paracetamol overdose, initiation of treatment should not be delayed pending the development of clinical symptoms intervention must begin as soon as a toxic ingestion is suspected. For mucolytic indications, the number of doses and treatment duration will be guided by the clinician's assessment of the patient's respiratory response. Do not mix Mucomix Injection with antibiotics in the same infusion unless directed by the prescribing professional, as interactions may reduce the efficacy of both agents.

Storage Advice:

Store unopened Mucomix Injection ampoules in a cool, dry place below 25°C, away from direct sunlight and sources of heat. Do not freeze. Once the ampoule has been opened, the contents must be used immediately and any unused solution must be discarded do not retain opened ampoules for later use. Handle with standard pharmaceutical care; the solution should be visually inspected for particulates or discolouration prior to administration, and any ampoule showing signs of damage or compromise should not be used. Store in compliance with local controlled medicine handling protocols where applicable. Do not use after the best-before date printed on the ampoule or outer packaging.

About the Brand:

Samarth Life Sciences Pvt. Ltd. traces its origins to 1963, founded by Mr. Gunwantlal Shah in Mumbai, Maharashtra, with a mission to bring life-saving critical care molecules to the Indian medical fraternity and global markets. Operating under stringent WHO-GMP compliant manufacturing standards, with facilities in Baddi (Himachal Pradesh) and Tumkur (Karnataka) approved by major international regulatory bodies, Samarth has built a reputation for pharmaceutical integrity and clinical relevance across decades of operation. The company's R&D philosophy is firmly anchored in addressing unmet medical needs through innovative, proprietary formulations particularly in the domains of critical care, hepatology, pulmonology, and emergency medicine. Samarth's products, including Mucomix, are exported to South America, the United Kingdom, South East Asia, and multiple African markets, reflecting a global trust in their manufacturing quality and therapeutic efficacy. This unwavering commitment to rigorous standards and life-saving innovation aligns with Animeal's commitment to providing only the most credible, clinically grounded pharmaceutical solutions for your pet's care. Discover Samarth Life Sciences today.

Disclaimer:

Please note that while Mucomix Injection is formulated from N-Acetylcysteine (400 mg/2 ml), a clinically established mucolytic and hepatoprotective agent, and is appropriate for use in companion animals including dogs and cats under veterinary supervision on an extra-label basis, it is a prescription-only injectable pharmaceutical and must not be purchased, possessed, or administered without a valid prescription from a licensed veterinarian. This product is not a substitute for a comprehensive veterinary diagnosis, and its use in a toxicity emergency requires immediate professional assessment do not attempt to treat a suspected paracetamol overdose at home. For pets with pre-existing respiratory conditions, asthma, bronchospasm, known hypersensitivity to acetylcysteine, or concurrent medications, consult your veterinarian before administration. Animeal supports your pet's health and happiness journey but does not replace the advice of a qualified veterinary professional.

Q: Is Mucomix Injection suitable for all animals, including dogs and cats of all ages and breeds?
Mucomix Injection, containing N-Acetylcysteine, is used in veterinary practice for dogs and cats on an extra-label basis, legally prescribed by veterinarians when clinically indicated primarily for paracetamol (acetaminophen) toxicity and select respiratory conditions. It is not formally approved for animal use by regulatory bodies and must only be administered following a veterinarian's explicit prescription and dose calculation. Breed, age, weight, and the patient's overall health status are critical factors in determining suitability and dosing all of which must be assessed by your attending veterinarian prior to use.
Q: How often is Mucomix Injection administered?
The frequency and duration of Mucomix Injection administration is determined entirely by the prescribing veterinarian based on the clinical indication. In paracetamol toxicity cases, it is typically delivered as a series of intravenous infusions over a defined treatment period beginning immediately upon diagnosis. For mucolytic respiratory indications, the dosing regimen is tailored to the patient's clinical response and the severity of the condition. This is strictly a clinic-administered treatment your pet's veterinarian will manage all aspects of the dosing schedule.
Q: How effective is Mucomix Injection for treating paracetamol toxicity and respiratory conditions in pets?
N-Acetylcysteine is the internationally recognised standard-of-care antidote for paracetamol overdose and is most effective when administered within 8 hours of a suspected toxic ingestion, where it can significantly reduce or even prevent serious liver damage. Effectiveness diminishes with time, though administration up to 24 hours post-ingestion still provides meaningful hepatoprotection. As a mucolytic, NAC's ability to cleave disulfide bonds in mucus has been well-established across decades of clinical use, with documented improvements in airway clearance and respiratory comfort in animals with mucus-related respiratory conditions.
Q: Are there any side effects or safety concerns associated with Mucomix Injection?
The most commonly reported side effects of intravenous N-Acetylcysteine include skin reactions such as rash, urticaria, flushing, and itching, which are typically managed within the clinical setting. In rare cases, more significant reactions including bronchospasm or blood pressure changes may occur, particularly in animals with underlying asthma or hypersensitivity histories. Because all administration takes place under direct veterinary supervision, any adverse reactions are monitored and managed in real time. The overall safety profile of NAC at therapeutic doses is well characterised, and serious complications are uncommon when it is properly administered by qualified professionals.
Q: How can I purchase Mucomix Injection through Animeal?
Mucomix Injection is available on Animeal's platform at animeal.in as a prescription-only pharmaceutical. To complete your purchase, a valid prescription issued by a licensed veterinarian is required at the time of order. You may upload your prescription directly on the product page, and our team will verify it promptly before dispatch. Animeal ensures secure, reliable delivery to your doorstep, and our customer care team is available to guide you through the prescription upload and ordering process for any questions you may have.
MUCOMIX INJ - Animeal
Rx Required
🚚 FREE delivery on orders above ₹499
10 DaysEasy Returns
100%Authentic
SecurePayments
INJECTABLE

MUCOMIX INJ

By SAMARTH
₹ 45.00
You save ₹ 5.00 (10%)
MRP ₹ 50.00 (Incl. taxes)

In Stock

Expires on or after: Jun, 2027
Size
₹ 45.00
MRP ₹ 50.00  10% OFF
1
Check Availability

Mucomix Injection by Samarth Life Sciences is a prescription-only, clinically critical injectable formulation of N-Acetylcysteine (NAC), designed to address two of the most urgent medical emergencies encountered in both human and veterinary clinical settings paracetamol (acetaminophen) toxicity and the management of thick, obstructive mucus secretions in respiratory tract diseases. Paracetamol overdose is one of the leading causes of acute liver failure, and the therapeutic window for effective intervention is dangerously narrow making the rapid, accurate administration of this antidote a life-or-death decision. Simultaneously, in conditions such as bronchitis, emphysema, bronchiectasis, and cystic fibrosis, excessive and viscous mucus can severely compromise airway patency and respiratory function. Mucomix Injection targets both these pathologies through a single, well-established active molecule with decades of clinical validation. Animeal is proud to offer Mucomix Injection as part of our curated selection of critical care pharmaceutical solutions for veterinary use, available for prescription-guided purchase through our platform.

Ingredients:

N-Acetylcysteine (NAC) 400 mg per 2 ml ampoule: (N-acetyl-L-cysteine; CAS No. 616-91-1) N-Acetylcysteine is a synthetic derivative of the naturally occurring amino acid L-cysteine, and its therapeutic action operates across two distinct but interconnected physiological pathways.

As a Mucolytic Agent: NAC directly targets the disulfide bonds within the glycoprotein matrix of mucus. At the biochemical level, its free thiol (-SH) group cleaves the disulfide bridges that maintain the structural rigidity and high viscosity of mucus polymers. This depolymerisation of mucus macromolecules reduces mucosal viscosity and elasticity, facilitating mucociliary clearance and making expectoration significantly easier. This action alleviates airway obstruction and improves respiratory function in conditions characterised by mucus hypersecretion.

As a Hepatoprotective Antidote: In the context of paracetamol toxicity, NAC functions as both a direct precursor to glutathione (GSH) and as a direct antioxidant. When paracetamol is metabolised in excess, the cytochrome P450 enzyme system generates a highly reactive hepatotoxic metabolite, N-acetyl-p-benzoquinone imine (NAPQI). Under normal conditions, NAPQI is rapidly conjugated and neutralised by hepatic glutathione. In overdose scenarios, glutathione stores become rapidly depleted, allowing NAPQI to accumulate and covalently bind to hepatocellular proteins, triggering oxidative stress, mitochondrial dysfunction, and ultimately necrotic cell death. NAC replenishes intracellular cysteine stores the rate-limiting substrate for glutathione biosynthesis thereby restoring GSH levels, neutralising NAPQI, and protecting hepatocytes from irreversible damage. Additionally, NAC exerts direct antioxidant activity, scavenging reactive oxygen species (ROS) independently of the GSH pathway, and improves microcirculatory blood flow in the liver, further reinforcing hepatic recovery.

Critical-Window Liver Protection in Toxicity Emergencies:

Mucomix Injection delivers N-Acetylcysteine intravenously, restoring hepatic glutathione reserves within the critical 8-hour post-overdose window during which liver damage is most reversible. For cases presenting beyond this window, the formulation continues to provide meaningful hepatoprotection up to 24 hours post-ingestion, making it the preferred choice of emergency and veterinary clinicians managing acute paracetamol toxicity in companion animals and human patients alike.

Cutting-Edge Mucolytic Action for Respiratory Clearance:

By directly cleaving the molecular bonds that give pathological mucus its gel-like consistency, Mucomix Injection restores natural mucociliary clearance and alleviates the airway obstruction that defines chronic bronchopulmonary conditions. In pets suffering from upper respiratory infections or structural lung diseases, this mucus-thinning action can be the difference between distressed, laboured breathing and restored respiratory comfort.

Dual-Pathway Antioxidant Defence:

Beyond its role as a glutathione precursor, NAC directly scavenges free radicals and reactive oxygen species at the cellular level, providing a second independent layer of antioxidant protection. This dual mechanism makes Mucomix Injection particularly valuable in clinical scenarios where oxidative stress from toxin exposure or chronic pulmonary inflammation is driving progressive organ or tissue damage.

Rapid Intravenous Bioavailability:

As an injectable formulation administered intravenously, Mucomix bypasses the limitations of oral bioavailability entirely, delivering therapeutic concentrations of N-Acetylcysteine directly into systemic circulation with immediate onset. This pharmacokinetic advantage is decisive in time-critical emergencies, where every hour without adequate antidotal intervention increases the risk of irreversible liver damage.

Clinically Validated Safety Profile:

N-Acetylcysteine has an extensive, well-characterised safety record across decades of clinical use in both human and veterinary medicine. Its side effect profile is well understood and manageable by qualified clinicians, and its mechanism of action is non-toxic to healthy hepatocytes, making it a reliable tool in the hands of experienced veterinary and medical professionals.

How to Use:

Mucomix Injection must be administered exclusively by a qualified veterinarian or licensed medical professional in a clinical or hospital setting. It is not suitable for self-administration under any circumstances. The injection is delivered as an intravenous infusion (IV drip) and must be appropriately diluted in a compatible IV solution as directed by the attending clinician. The dose, infusion rate, and duration of treatment are determined by the veterinarian or physician based on the species, body weight, the nature and severity of the presenting condition, and the time elapsed since toxic exposure. In the context of paracetamol overdose, initiation of treatment should not be delayed pending the development of clinical symptoms intervention must begin as soon as a toxic ingestion is suspected. For mucolytic indications, the number of doses and treatment duration will be guided by the clinician's assessment of the patient's respiratory response. Do not mix Mucomix Injection with antibiotics in the same infusion unless directed by the prescribing professional, as interactions may reduce the efficacy of both agents.

Storage Advice:

Store unopened Mucomix Injection ampoules in a cool, dry place below 25°C, away from direct sunlight and sources of heat. Do not freeze. Once the ampoule has been opened, the contents must be used immediately and any unused solution must be discarded do not retain opened ampoules for later use. Handle with standard pharmaceutical care; the solution should be visually inspected for particulates or discolouration prior to administration, and any ampoule showing signs of damage or compromise should not be used. Store in compliance with local controlled medicine handling protocols where applicable. Do not use after the best-before date printed on the ampoule or outer packaging.

About the Brand:

Samarth Life Sciences Pvt. Ltd. traces its origins to 1963, founded by Mr. Gunwantlal Shah in Mumbai, Maharashtra, with a mission to bring life-saving critical care molecules to the Indian medical fraternity and global markets. Operating under stringent WHO-GMP compliant manufacturing standards, with facilities in Baddi (Himachal Pradesh) and Tumkur (Karnataka) approved by major international regulatory bodies, Samarth has built a reputation for pharmaceutical integrity and clinical relevance across decades of operation. The company's R&D philosophy is firmly anchored in addressing unmet medical needs through innovative, proprietary formulations particularly in the domains of critical care, hepatology, pulmonology, and emergency medicine. Samarth's products, including Mucomix, are exported to South America, the United Kingdom, South East Asia, and multiple African markets, reflecting a global trust in their manufacturing quality and therapeutic efficacy. This unwavering commitment to rigorous standards and life-saving innovation aligns with Animeal's commitment to providing only the most credible, clinically grounded pharmaceutical solutions for your pet's care. Discover Samarth Life Sciences today.

Disclaimer:

Please note that while Mucomix Injection is formulated from N-Acetylcysteine (400 mg/2 ml), a clinically established mucolytic and hepatoprotective agent, and is appropriate for use in companion animals including dogs and cats under veterinary supervision on an extra-label basis, it is a prescription-only injectable pharmaceutical and must not be purchased, possessed, or administered without a valid prescription from a licensed veterinarian. This product is not a substitute for a comprehensive veterinary diagnosis, and its use in a toxicity emergency requires immediate professional assessment do not attempt to treat a suspected paracetamol overdose at home. For pets with pre-existing respiratory conditions, asthma, bronchospasm, known hypersensitivity to acetylcysteine, or concurrent medications, consult your veterinarian before administration. Animeal supports your pet's health and happiness journey but does not replace the advice of a qualified veterinary professional.

Q: Is Mucomix Injection suitable for all animals, including dogs and cats of all ages and breeds?
Mucomix Injection, containing N-Acetylcysteine, is used in veterinary practice for dogs and cats on an extra-label basis, legally prescribed by veterinarians when clinically indicated primarily for paracetamol (acetaminophen) toxicity and select respiratory conditions. It is not formally approved for animal use by regulatory bodies and must only be administered following a veterinarian's explicit prescription and dose calculation. Breed, age, weight, and the patient's overall health status are critical factors in determining suitability and dosing all of which must be assessed by your attending veterinarian prior to use.
Q: How often is Mucomix Injection administered?
The frequency and duration of Mucomix Injection administration is determined entirely by the prescribing veterinarian based on the clinical indication. In paracetamol toxicity cases, it is typically delivered as a series of intravenous infusions over a defined treatment period beginning immediately upon diagnosis. For mucolytic respiratory indications, the dosing regimen is tailored to the patient's clinical response and the severity of the condition. This is strictly a clinic-administered treatment your pet's veterinarian will manage all aspects of the dosing schedule.
Q: How effective is Mucomix Injection for treating paracetamol toxicity and respiratory conditions in pets?
N-Acetylcysteine is the internationally recognised standard-of-care antidote for paracetamol overdose and is most effective when administered within 8 hours of a suspected toxic ingestion, where it can significantly reduce or even prevent serious liver damage. Effectiveness diminishes with time, though administration up to 24 hours post-ingestion still provides meaningful hepatoprotection. As a mucolytic, NAC's ability to cleave disulfide bonds in mucus has been well-established across decades of clinical use, with documented improvements in airway clearance and respiratory comfort in animals with mucus-related respiratory conditions.
Q: Are there any side effects or safety concerns associated with Mucomix Injection?
The most commonly reported side effects of intravenous N-Acetylcysteine include skin reactions such as rash, urticaria, flushing, and itching, which are typically managed within the clinical setting. In rare cases, more significant reactions including bronchospasm or blood pressure changes may occur, particularly in animals with underlying asthma or hypersensitivity histories. Because all administration takes place under direct veterinary supervision, any adverse reactions are monitored and managed in real time. The overall safety profile of NAC at therapeutic doses is well characterised, and serious complications are uncommon when it is properly administered by qualified professionals.
Q: How can I purchase Mucomix Injection through Animeal?
Mucomix Injection is available on Animeal's platform at animeal.in as a prescription-only pharmaceutical. To complete your purchase, a valid prescription issued by a licensed veterinarian is required at the time of order. You may upload your prescription directly on the product page, and our team will verify it promptly before dispatch. Animeal ensures secure, reliable delivery to your doorstep, and our customer care team is available to guide you through the prescription upload and ordering process for any questions you may have.
MUCOMIX INJ
₹ 45.00
₹ 50.00  10% OFF

Frequently Asked Questions

Is Mucomix Injection suitable for all animals, including dogs and cats of all ages and breeds?

Mucomix Injection, containing N-Acetylcysteine, is used in veterinary practice for dogs and cats on an extra-label basis, legally prescribed by veterinarians when clinically indicated primarily for paracetamol (acetaminophen) toxicity and select respiratory conditions. It is not formally approved for animal use by regulatory bodies and must only be administered following a veterinarian's explicit prescription and dose calculation. Breed, age, weight, and the patient's overall health status are critical factors in determining suitability and dosing all of which must be assessed by your attending veterinarian prior to use.

How often is Mucomix Injection administered?

The frequency and duration of Mucomix Injection administration is determined entirely by the prescribing veterinarian based on the clinical indication. In paracetamol toxicity cases, it is typically delivered as a series of intravenous infusions over a defined treatment period beginning immediately upon diagnosis. For mucolytic respiratory indications, the dosing regimen is tailored to the patient's clinical response and the severity of the condition. This is strictly a clinic-administered treatment your pet's veterinarian will manage all aspects of the dosing schedule.

How effective is Mucomix Injection for treating paracetamol toxicity and respiratory conditions in pets?

N-Acetylcysteine is the internationally recognised standard-of-care antidote for paracetamol overdose and is most effective when administered within 8 hours of a suspected toxic ingestion, where it can significantly reduce or even prevent serious liver damage. Effectiveness diminishes with time, though administration up to 24 hours post-ingestion still provides meaningful hepatoprotection. As a mucolytic, NAC's ability to cleave disulfide bonds in mucus has been well-established across decades of clinical use, with documented improvements in airway clearance and respiratory comfort in animals with mucus-related respiratory conditions.

Are there any side effects or safety concerns associated with Mucomix Injection?

The most commonly reported side effects of intravenous N-Acetylcysteine include skin reactions such as rash, urticaria, flushing, and itching, which are typically managed within the clinical setting. In rare cases, more significant reactions including bronchospasm or blood pressure changes may occur, particularly in animals with underlying asthma or hypersensitivity histories. Because all administration takes place under direct veterinary supervision, any adverse reactions are monitored and managed in real time. The overall safety profile of NAC at therapeutic doses is well characterised, and serious complications are uncommon when it is properly administered by qualified professionals.

How can I purchase Mucomix Injection through Animeal?

Mucomix Injection is available on Animeal's platform at animeal.in as a prescription-only pharmaceutical. To complete your purchase, a valid prescription issued by a licensed veterinarian is required at the time of order. You may upload your prescription directly on the product page, and our team will verify it promptly before dispatch. Animeal ensures secure, reliable delivery to your doorstep, and our customer care team is available to guide you through the prescription upload and ordering process for any questions you may have.
View All Questions